Frequently asked questions about studies, publications and working together

The questions manufacturers ask most often before the first conversation.

Collaboration and budget

You receive a fixed-price quote in advance that you can present internally. You pay for a result, with no new hire and no non-wage labour costs. This is exactly why many manufacturers bring in external support instead of a permanent employee.

That depends on the data situation and scope. The evidence call costs you nothing. After that, you receive a fixed-price offer before anything starts. Our Evidence Plan shows you a first budget range.

I am, from the first conversation to the publication. You always speak to me directly.

Yes. Many of our projects run under non-disclosure, which is why we do not name clients on this website. We are happy to sign a confidentiality agreement before any data are exchanged.

Little. You send your documents once and align with us at short notice when there is something to decide. Protocol, ethics application, sites, analysis and manuscript are on our side. You only have to approve what you sign as the manufacturer.

Data, physicians and data protection

Especially then. There is usually more available than manufacturers think: in user hospitals, registries and routine data. We check what can be used and close the gaps in a targeted way.

That is part of my job. I bring physicians from my network, follow up with your users and travel to site if needed until the data are in. The physicians involved publish as co-authors, which is often the reason they take part.

Yes, if ethics approval, data protection and contracts are properly prepared. We handle that together with the physician so that the hospital administration can give its consent.

Speed and deadlines

Once all data are available, you have the first draft of a case report or case series after 72 hours, of a retrospective study after about 1 week, and of a white paper or a large study after about 2 weeks. What takes longer is whatever comes from outside: an ethics committee often meets only once a month, and for new studies patients first have to be enrolled.

That depends on what is missing and how much time is left. Analysing existing data often takes just a few months, whereas a new study with a publication takes longer. In the first conversation, we will see what is realistic by your deadline, and I will tell you openly.

Services and limits

Not always. Registry data or an analysis of existing cases are often enough. In the evidence call, we clarify what your Notified Body actually wants to see and what you can save yourself.

No, we deliberately do not. We deliver the data and the evidence that go into these reports, prepared so that your regulatory team can take them over directly.

Large CROs are built for approval studies with many sites. For real-world evidence, registries and publications, what counts is short communication lines, physicians who take part, and someone who understands your indication clinically.

Yes. We build evidence in Germany, Austria and Switzerland, but also in countries such as Turkey or Colombia. Publication is in English.

Yes. I lead larger projects, up to and including initial approval, as prime contractor and bring in the right specialists from my network. If you wish, I will also step into management temporarily.

When do you have to start on evidence at the latest?

Answer 18 short questions about your product. You then receive your Evidence Plan as a PDF: which building blocks must be ready by your next deadline, when you have to start at the latest, and what budget to expect.

Create your Evidence Plan Takes 4 minutes, is confidential and free of charge.
Example of the Evidence Plan result: deadline, latest start, budget range and timeline of the building blocks

This is what your result looks like (example)

Your question is not here?

Then ask me directly, in the evidence call or by email at pr@recknagel-scientific-consulting.de.